• Cancer Research Horizons is the innovation engine of Cancer Research UK – the world’s largest charitable funder of cancer research.
• We bring together world-leading minds, bold ideas and the right partners to bridge the gap between academic research and taking drugs to market. We focus on the tougher, more profound ideas that can lead to true innovation, translating them into effective treatments and diagnostics for cancer patients.
• Our six drug discovery sites offer researchers and partners access to the full spectrum of drug discovery, covering the entire journey; translating early concepts to patient benefit.
• Our breadth of world-leading capabilities is underpinned by deep biology, pharmacology and medicinal chemistry knowledge and expertise.
• To date, we’ve played an instrumental role in forming over 60 spin-out companies and helped bring 11 cancer drugs to market, borne out of Cancer Research UK’s pioneering research. Through these drugs, we have enabled in excess of 6 million courses of treatment for cancer patients across the world.
• By uniting our commercial partnerships and therapeutic innovation capabilities, Cancer Research Horizons is uniquely placed to support translational funding, licensing and collaboration, spin out creation, and offer a full spectrum of drug discovery and clinical capabilities.
